Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07587073 · ClinicalTrials.gov registry record · NA

Comprehensive Enhanced Care Management Under CalAIM for High-Risk Medi-Cal Members

A NA study, sponsored by StratiHealth.

Not yet
Registry status
NA
Development phase
1,200
Enrollment target

NCT07587073: Clinical Trial NA study, sponsored by StratiHealth.

NCT07587073 is a NA study that has not yet begun recruiting, run by StratiHealth. The registered enrollment target is 1,200 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (15% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07587073, a NA study, has not yet begun recruiting, sponsored by StratiHealth.

NOT YET RECRUITING
Registry status
NA
Development phase
1,200 participants
Enrollment target

Study Summary

This pragmatic, cluster-randomized trial will evaluate whether a comprehensive CalAIM-aligned care model consisting of Enhanced Care Management, selected Community Supports, Transitional Care Services, and residential care coordination improves population health outcomes among high-risk Medi-Cal managed care members in California compared with usual CalAIM service delivery. The intervention is intended to improve continuity of care after discharge, reduce potentially avoidable utilization, increase successful linkage to outpatient and social supports, and improve community tenure and patient-reported outcomes.

Primary Outcome

Proportion of enrolled participants experiencing an unplanned all-cause inpatient readmission within 30 days after index discharge or index transition episode.

Interventions

  • BEHAVIORAL Comprehensive CalAIM Care Bundle
  • OTHER Usual CalAIM Service Delivery

Trial Details

FieldValue
Enrollment Target 1,200 participants
Start Date 2026-10-01
Est. Completion 2028-12-31
Phase NA
StratiHealth

4 total trials

What is known before NCT07587073 opens enrollment

NCT07587073 is an interventional study that assigns participants to a tested intervention. Its 1,200 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (15% lower).

The record links to 0 conditions, and to 2 interventions - of which Comprehensive CalAIM Care Bundle is the first listed.

NCT07587073 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07587073 about?

NCT07587073 is a clinical study titled "Comprehensive Enhanced Care Management Under CalAIM for High-Risk Medi-Cal Members". This pragmatic, cluster-randomized trial will evaluate whether a comprehensive CalAIM-aligned care model consisting of Enhanced Care Management, selected Community Supports, Transitional Care Services, and residential care coordination improves population health outcomes among high-risk Medi-Cal man...

What is the current status of trial NCT07587073?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 1,200 participants. The study started on 2026-10-01. Estimated completion is 2028-12-31.

What interventions are being tested in trial NCT07587073?

The interventions under investigation include: Comprehensive CalAIM Care Bundle (BEHAVIORAL), Usual CalAIM Service Delivery (OTHER).

Who is sponsoring clinical trial NCT07587073?

This trial is sponsored by StratiHealth, which has 4 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT07587073's enrollment target sits among peer trials

1,200 83rd of 2000 higher than 1,912 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00001987 · 1,200 participants

    Genetic Studies of Insulin and Diabetes

  • NCT00477100 · 1,200 participants

    Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer

  • NCT01209000 · 1,200 participants

    Nephrotic Syndrome Study Network

  • NCT01944332 · 1,200 participants · NA

    Gamete Treatment to Correct Fertilization Failure

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07587073, the US trial registry maintained by the National Library of Medicine. NCT07587073 (large enrollment · none site footprint · not yet recruiting) retrieved and formatted by PlainTrial, see methodology.